Tandem Diabetes Care Inc (TNDM) gets rating Initiated from Mizuho

In a filing, Tandem Diabetes Care Inc revealed its EVP & Chief Operating Officer Kyrillos Jean-Claude acquired Company’s shares for reported $0.19 million on Mar 07 ’25. In the deal valued at $18.12 per share,10,538 shares were bought. As a result of this transaction, Kyrillos Jean-Claude now holds 10,538 shares worth roughly $0.22 million.

Then, BLICKENSTAFF KIM D sold 30,000 shares, generating $941,400 in total proceeds. Upon selling the shares at $31.38, the Director now owns 165,190 shares.

Before that, BLICKENSTAFF KIM D sold 10,000 shares. Tandem Diabetes Care Inc shares valued at $300,000 were divested by the Director at a price of $30.00 per share. As a result of the transaction, BLICKENSTAFF KIM D now holds 195,190 shares, worth roughly $4.05 million.

Mizuho initiated its Tandem Diabetes Care Inc [TNDM] rating to a Neutral in a research note published on April 10, 2025; the price target was $20. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in early March from “an Overweight” to “an Equal-weight”. Citigroup also remained covering TNDM and has decreased its forecast on March 04, 2025 with a “Neutral” recommendation from previously “Buy” rating. Wells Fargo revised its rating on March 03, 2025. It rated TNDM as “an Equal weight” which previously was an “an Overweight”.

Price Performance Review of TNDM

On Friday, Tandem Diabetes Care Inc [NASDAQ:TNDM] saw its stock fall -0.76% to $20.76. Over the last five days, the stock has lost -0.10%. Tandem Diabetes Care Inc shares have fallen nearly -42.37% since the year began. Nevertheless, the stocks have fallen -57.10% over the past one year. While a 52-week high of $48.24 was reached on 01/06/25, a 52-week low of $15.75 was recorded on 04/07/25.

Levels Of Support And Resistance For TNDM Stock

The 24-hour chart illustrates a support level at 20.31, which if violated will result in even more drops to 19.85. On the upside, there is a resistance level at 21.22. A further resistance level may holdings at 21.68.

How much short interest is there in Tandem Diabetes Care Inc?

A steep rise in short interest was recorded in Tandem Diabetes Care Inc stocks on 2025-05-30, growing by 0.95 million shares to a total of 7.83 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 6.88 million shares. There was a rise of 12.17%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.